跳至主要内容
临床试验/IRCT2015071722965N2
IRCT2015071722965N2已完成2 期

Evaluating the effects of oral N-acetyl cysteine as a Adjuvant therapy on controling clinical symtoms and serum level of inflammatory biomarkers including IL6,TNF-a, CRP and ESR in rhumatoid arthritis Patients

Vice chancellor for research, Hamadan University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with diagnosis of arthritis rhumatoid; Patients more than 18 years and less than 65 years; Patients with moderate to severe active disease
  • Exclusion criteria: Patients with active infection; Patients with mild active disease

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Hamadan University of Medical Sciences

相似试验